Inventor · disambiguated record
Hiromi Kumon
Also filed as: KUMON HIROMI
15 granted patents·9 pending applications·55 citations·filing 2006–2021
91Inventor score
Files withKUMON HIROMI10MOMOTARO GENE INC5NAT UNIV CORPORATION OKAYAMA UNIV3ISHIKAWA TOMOKAZU2MATSUURA EIJI1
Top patents by PatentIndex Score
24 records- 0192US10071126B2Conditionally replicating adenovirus to express REIC geneNAT UNIV CORPORATION OKAYAMA UNIV·Filed 2015·Granted Sep 11, 2018·9 cites·6 claims
- 0288US8658611B2Apoptosis-inducing agent for prostate cancer cellsKUMON HIROMI·Filed 2011·Granted Feb 25, 2014·7 cites·6 claims
- 0387US8410251B2Antibody against calcified globule and use of the sameMATSUURA EIJI·Filed 2009·Granted Apr 2, 2013·13 cites·16 claims
- 0481US9644013B2Partial region polypeptide of REIC/Dkk-3 proteinNAT UNIV CORP OKAYAMA UNIV·Filed 2016·Granted May 9, 2017·3 cites·6 claims
- 0579US11484592B2Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitorMOMOTARO GENE INC·Filed 2017·Granted Nov 1, 2022·2 cites·2 claims
- 0677US9458513B2Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using sameISHIKAWA TOMOKAZU·Filed 2011·Granted Oct 4, 2016·1 cites·7 claims
- 0777US8618273B2Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the sameKUMON HIROMI·Filed 2007·Granted Dec 31, 2013·4 cites·7 claims
- 0876US9493776B2System for increasing gene expression and vector comprising the systemKUMON HIROMI·Filed 2010·Granted Nov 15, 2016·2 cites·16 claims
- 0976US8658612B2Therapeutic agent for malignant mesothelioma and immunostimulantKUMON HIROMI·Filed 2009·Granted Feb 25, 2014·3 cites·3 claims
- 1075US9475865B2Direct administration of REIC/Dkk-3 to mesotheliomaKUMON HIROMI·Filed 2013·Granted Oct 25, 2016·2 cites·2 claims
- 1174US9222107B2REIC-expressing adenovirus vectorKUMON HIROMI·Filed 2012·Granted Dec 29, 2015·4 cites·8 claims
- 1274US8614093B2Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activityKUMON HIROMI·Filed 2009·Granted Dec 24, 2013·2 cites·4 claims
- 1373US8946173B2Cancer cell death inducing agent having effects of potentiating anticancer drug against anticancer-drug-resistant cancerKUMON HIROMI·Filed 2008·Granted Feb 3, 2015·3 cites·3 claims
- 1458US2010323365A1Primer and probe for detecting chlamydophila caviae, as well as a chlamydophila caviae detection method using the sameISHIKAWA TOMOKAZU·Filed 2009·Application pending·0 cites
- 1553US2023310653A1THERAPEUTIC AGENT FOR EGFR GENE MUTATION-POSITIVE LUNG CANCER COMPRISING REIC/Dkk-3 GENEMOMOTARO GENE INC·Filed 2021·Application pending·0 cites
- 1649US2013267025A1Partial Region Polypeptide of REIC/Dkk-3 ProteinKUMON HIROMI·Filed 2011·Application pending·0 cites
- 1749US2009005538A1Apoptosis-Inducing Agent for Prostate Cancer CellsKUMON HIROMI·Filed 2006·Application pending·0 cites
- 1848US2015284444A1Pharmaceutical composition for cancer treatment including fusion proteinWATANABE MASAMI·Filed 2013·Application pending·0 cites
- 1947US11951182B2Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitorMOMOTARO GENE INC·Filed 2019·Granted Apr 9, 2024·0 cites·6 claims
- 2047US2022280601A1METHOD FOR TREATMENT OF HEPATIC CANCER USING REIC/Dkk-3 GENE IN COMBINATION WITH ANTI-TUMOR AGENTMOMOTARO GENE INC·Filed 2020·Application pending·0 cites
- 2146US10782296B2Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having active structure and monitoring of cancer treatment using such anti-REIC/Dkk-3 antibodyNAT UNIV CORPORATION OKAYAMA UNIV·Filed 2016·Granted Sep 22, 2020·0 cites·4 claims
- 2245US2014056945A1Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activityMOMOTARO GENE INC·Filed 2013·Application pending·0 cites
- 2338US2018265894A1Gene Expression Cassette And Product ThereofNAT UNIV CORPORATION OKAYAMA UNIV·Filed 2016·Application pending·0 cites
- 2437US2019330291A1TGFß INHIBITOR CONTAINING REIC/Dkk-3 PROTEIN AS ACTIVE INGREDIENTMOMATARO GENE INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiromi Kumon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →